UK markets closed

IDEX Biometrics ASA (IDBA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
10.000.00 (0.00%)
As of 01:10PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 123.73M
Enterprise value 98.44M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)47.38
Price/book (mrq)5.09
Enterprise value/revenue 30.71
Enterprise value/EBITDA -3.26

Trading information

Stock price history

Beta (5Y monthly) 2.39
52-week change 3-45.68%
S&P500 52-week change 3-13.03%
52-week high 331.62
52-week low 37.78
50-day moving average 310.58
200-day moving average 319.09

Share statistics

Avg vol (3-month) 31.11k
Avg vol (10-day) 3180
Shares outstanding 513.5M
Implied shares outstanding 6N/A
Float 811.28M
% held by insiders 13.60%
% held by institutions 10.02%
Shares short (14 Jun 2022) 42.9k
Short ratio (14 Jun 2022) 45.42
Short % of float (14 Jun 2022) 4N/A
Short % of shares outstanding (14 Jun 2022) 40.02%
Shares short (prior month 12 May 2022) 44.01k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-994.66%

Management effectiveness

Return on assets (ttm)-56.74%
Return on equity (ttm)-106.06%

Income statement

Revenue (ttm)3.21M
Revenue per share (ttm)0.22
Quarterly revenue growth (yoy)58.50%
Gross profit (ttm)1.59M
EBITDA -30.9M
Net income avi to common (ttm)-33.14M
Diluted EPS (ttm)-2.62
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)25.53M
Total cash per share (mrq)1.89
Total debt (mrq)235k
Total debt/equity (mrq)0.76
Current ratio (mrq)8.23
Book value per share (mrq)2.33

Cash flow statement

Operating cash flow (ttm)-29.07M
Levered free cash flow (ttm)-16.22M